1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > NRT Smoking Cessation Aids in India

NRT Smoking Cessation Aids in India

  • September 2016
  • -
  • Euromonitor International
  • -
  • 24 pages

Cigarette smoking remained a major health concern over the review period, with the government further regulating cigarettes sales in India. As such, these movements benefited sales of NRT gum, the only category present in smoking cessation aids in the country. According to Euromonitor International’s Countries & Consumers data, smoking prevalence in India is set to fall from 11.9% in 2009 to 11.5% in 2020, with an increasing number of smokers trying to kick the habit.

Euromonitor International’s NRT Smoking Cessation Aids in India report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

NRT Smoking Cessation Aids in India
NRT SMOKING CESSATION AIDS IN INDIA
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2011-2016
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016
Table 4 Sales of NRT Gum by Flavour: % Value 2011-2016
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2012-2016
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2013-2016
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Executive Summary
Consumer Health Enjoys Positive Value Growth in 2016
Government Action Against A Number of Drugs Impacts OTC
Herbal/ayurvedic Players Continue To Have A Stronger Impact on Consumer Health
Chemists/pharmacies and Parapharmacies/drugstores Continue To Grow
Consumer Health Is Forecast To Register Positive Growth
Key Trends and Developments
Lack of Proper Policy Leads To Ongoing Overlapping of OTC and Rx Brands
Consumer Health Sales Are Set To Be Driven by Self-medication and A More Progressive Approach
Constant Rising Demand for Ayurvedic/herbal Option Opens Significant Opportunities
Territory Key Trends and Developments
East and Northeast India
North India
South India
West India
Rural Vs Urban Key Trends and Developments
Trends
Competitive Landscape
Prospects
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 10 Life Expectancy at Birth 2011-2016
Market Data
Table 11 Sales of Consumer Health by Category: Value 2011-2016
Table 12 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 13 Sales of Consumer Health by Region: Value 2011-2016
Table 14 Sales of Consumer Health by Region: % Value Growth 2011-2016
Table 15 Sales of Consumer Health by Rural vs Urban: % Value 2016
Table 16 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 17 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 18 Distribution of Consumer Health by Format: % Value 2011-2016
Table 19 Distribution of Consumer Health by Format and Category: % Value 2016
Table 20 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 22 Forecast Sales of Consumer Health by Region: Value 2016-2021
Table 23 Forecast Sales of Consumer Health by Region: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Sources
Summary 1 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • $ 4250
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

OTC

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.